Skip to main content

2 Result(s)

within Article Remove this filter Yutaka Fujiwara Remove this filter Cancer Research Remove this filter Immunology Remove this filter

and

  1. No Access

    Article

    Predictive value of serum VEGF levels for elderly patients or for patients with poor performance status receiving anti-PD-1 antibody therapy for advanced non-small-cell lung cancer

    The efficacy of immune checkpoint inhibitors (ICIs) in elderly and poor performance status (PS) patients is controversial, because clinical evidence is limited. This study aimed to find a predictive biomarker ...

    Ryota Shibaki, Shuji Murakami, Yuki Shinno… in Cancer Immunology, Immunotherapy (2020)

  2. No Access

    Article

    Association of immune-related pneumonitis with the presence of preexisting interstitial lung disease in patients with non-small lung cancer receiving anti-programmed cell death 1 antibody

    The safety of anti-programmed cell death 1 (PD-1) antibody for patients with preexisting interstitial lung disease (ILD) remains unknown. The aim of this study was to evaluate the dependence of preexisting ILD...

    Ryota Shibaki, Shuji Murakami, Yuji Matsumoto… in Cancer Immunology, Immunotherapy (2020)